BlackRock
AGN

BlackRock’s Allergan plc AGN Stock Holding History

BlackRock’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-37,200
Closed -$7.09M – 5111
2018
Q3 		$7.09M Buy
+37,200
New +$6.83M ﹤0.01% 3385

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

BlackRock's AGN Position: Q2 2020 in Review

BlackRock sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 21,136,493 shares — an estimated $3.74B sold.

BlackRock first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $4.93B in Q1 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • BlackRock reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • BlackRock sold 21,136,493 Allergan plc shares in Q2 2020, an estimated $3.74B.
  • BlackRock first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • BlackRock's Allergan plc position peaked at $4.93B in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on BlackRock's 13F filing for Q2 2020, filed 14 Aug 2020.